niacinamide has been researched along with gossypol in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Benz, CC; Hollander, C; Keniry, MA | 1 |
Cárcamo, JG; Castro, M; Concha, II; Ojeda, L; Ojeda, P; Ortega, M; Pérez, A; Rauch, MC; Reyes, AM; Rivas, CI; Sánchez, C; Valenzuela, X; Vera, JC | 1 |
Dai, X; He, F; Lian, J; Ni, Z; Smith, AR; Su, C; Xu, L | 1 |
4 other study(ies) available for niacinamide and gossypol
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
The effect of gossypol and 6-aminonicotinamide on tumor cell metabolism: a 31P-magnetic resonance spectroscopic study.
Topics: 6-Aminonicotinamide; Breast Neoplasms; Cell Line; Female; Gossypol; Humans; Magnetic Resonance Spectroscopy; Mitochondria; Niacinamide; Nucleotides; Phosphates; Phospholipids; Phosphorus; Sugar Phosphates | 1989 |
Endofacial competitive inhibition of the glucose transporter 1 activity by gossypol.
Topics: 3-O-Methylglucose; Animals; Antigens, CD; Binding Sites; Binding, Competitive; CHO Cells; Cricetinae; Cricetulus; Cytochalasin B; Deoxyglucose; Dose-Response Relationship, Drug; Erythrocytes; Glucose; Glucose Transporter Type 1; Gossypol; HL-60 Cells; Humans; Kinetics; Models, Biological; Niacinamide; Receptor, Insulin; Spectrometry, Fluorescence; Transfection | 2009 |
Sorafenib sensitizes (-)-gossypol-induced growth suppression in androgen-independent prostate cancer cells via Mcl-1 inhibition and Bak activation.
Topics: Androgens; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; bcl-2 Homologous Antagonist-Killer Protein; Benzenesulfonates; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Synergism; Female; Gossypol; Humans; Male; Mice; Mice, Nude; Myeloid Cell Leukemia Sequence 1 Protein; Niacinamide; Phenylurea Compounds; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Pyridines; Sorafenib; Time Factors; Xenograft Model Antitumor Assays | 2012 |